Transition your customer engagement strategies to better demonstrate the value of your brand beyond cost savings.
Achieving your desired brand results with an overwhelmed customer base requires a fresh look at the way you go to market. By leveraging digital tools and personalized content, you can demonstrate the value of your brand beyond cost savings.
Do you have the training, development, and team in place to deliver on the requirements of HCPs and patients today and in the future?
Inizio Engage commissioned an independent market research report looking to understand what the future of HCP and patient engagement will look like, engaging 22 global Pharma leaders situated in Europe from a total of 12 pharmaceutical companies.
We then shared these insights with workshop attendees at industry conferences and gained real-time feedback on the investment and progress of this transformation.
While you’ll be very familiar with the trends dominating conversations, we believe it’s critical to continue interrogating where organizations really are on the customer engagement transformation journey.
84% of pharma leaders surveyed identified investment in non-promotional, MSL-led scientific engagement is ‘critical’ or ‘very important’.
“MSLs need to be more business-minded and comfortable engaging digitally, working with HCP engagement data, and partnering with HCPs to improve patient outcomes.”
58% of EU, 69% of US leaders surveyed are transforming the role of the sales rep to develop more scientifically informed partnerships with HCPs.
“There should be no difference between commercial and medical in terms of omnichannel. It’s there for the customer. The channels themselves they might be, some of them might be closer to scientific and medical discussion and others might be closer to let’s say commercial product storytelling, but they all need to interplay.”
For more market research and survey data, download our report:
